Zobrazeno 1 - 10 of 78 pro vyhledávání: '"Efectes secundaris dels medicaments"'
1
What Role for Long-Acting Injectable Antipsychotics in Managing Schizophrenia Spectrum Disorders in Children and Adolescents? A Systematic Review
Autor: Inmaculada Baeza, Adriana Fortea, Daniel Ilzarbe, Gisela Sugranyes
Publikováno v: Pediatric Drugs. 25:135-149
Background: Long-acting injectable antipsychotics (LAIAs) are an efficacious and well-tolerated treatment in adults with schizophrenia spectrum disorders (SSD). However, there is less evidence for their use in children and adolescents. Objectives: Th
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b590259b19aea5d2c463b9a9e32d611e
https://doi.org/10.1007/s40272-023-00558-x
Zobrazit plný text záznamu
2
Creatine Kinase Elevation in Autosomal Dominant Polycystic Kidney Disease Patients on Tolvaptan Treatment
Autor: Diana Rodríguez-Espinosa, José Jesús Broseta, Carla Bastida, María Isabel Álvarez-Mora, Carlos Nicolau, Cristina Alvarez, Irene Agraz-Pamplona, Maya Sánchez-Baya, Mónica Furlano, César Ruiz, Luis F. Quintana, Gastón J. Piñeiro, Esteban Poch, Roser Torra-Balcells, Miquel Blasco
Publikováno v: NEPHRON
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Background: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary cause of end-stage kidney disease. Currently, tolvaptan is the only treatment that has proven to delay disease progression. The most notable side effect of
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e38058d4b906c241f1c700bf5c67a17
https://doi.org/10.1159/000526368
Zobrazit plný text záznamu
3
Seqüeles dentals en adolescents sotmesos a tractament oncològic durant la primera infància
Autor: Rabassa Blanco, Judit
[cat] El càncer infantil és una de les principals causes de mortalitat durant la infància i l’adolescència. Segons l’Associació Espanyola contra el càncer, 1500 nens/es de 0 a 14 anys són diagnosticats anualment d’aquesta malaltia. Els t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______963::7fdd91de628454d4ba999d84d737828b
http://hdl.handle.net/2445/192143
Zobrazit plný text záznamu
5
Safety of nalmefene for the treatment of alcohol use disorder: an update
Autor: Antoni Gual, Wim van den Brink, Paola Zuluaga, Hugo López-Pelayo, Elsa Caballeria, Karl Mann
Publikováno v: Expert opinion on drug safety, 19(1), 9-17. Taylor and Francis Ltd.
Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Introduction: Reduced drinking has been debated as a treatment goal for heavy drinking alcohol-dependent patients, in whom treatment based on abstinence is not always an option. Nalmefene was the first drug approved by the European Medicines Agency (
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5ab9ea8e256f8776baf72b5a68b6ba
https://doi.org/10.1080/14740338.2020.1707802
Zobrazit plný text záznamu
6
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension
Autor: Marc Humbert, Gérald Simonneau, David Pittrow, Marion Delcroix, Joanna Pepke-Zaba, David Langleben, Lisa M. Mielniczuk, Pilar Escribano Subias, Repke J. Snijder, Joan A. Barberà, Jens Klotsche, Christian Meier, Marius M. Hoeper
EXPERT was an international, multicenter, prospective, uncontrolled, non-interventional cohort study in patients with pulmonary hypertension treated with riociguat. Patients were followed for 1-4 years, and the primary outcomes were adverse events (A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a06f8bbd00f4195d3c2101a61be260b
http://hdl.handle.net/2445/197012
Zobrazit plný text záznamu
7
Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcome
Autor: Elena Cortés‐Vicente, Rodrigo Álvarez‐Velasco, Francesc Pla‐Junca, Ricard Rojas‐Garcia, Carmen Paradas, Teresa Sevilla, Carlos Casasnovas, María Teresa Gómez‐Caravaca, Julio Pardo, Alba Ramos‐Fransi, Ana Lara Pelayo‐Negro, Gerardo Gutiérrez‐Gutiérrez, Janina Turon‐Sans, Adolfo López de Munain, Antonio Guerrero‐Sola, Ivonne Jericó, María Asunción Martín, María Dolores Mendoza, Germán Morís, Beatriz Vélez‐Gómez, Tania Garcia‐Sobrino, Elba Pascual‐Goñi, David Reyes‐Leiva, Isabel Illa, Eduard Gallardo
Publikováno v: Annals of Clinical and Translational Neurology
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Addi. Archivo Digital para la Docencia y la Investigación
ABACUS. Repositorio de Producción Científica
Universidad Europea (UEM)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
[Objective] To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis (MG) and to determine the effectiveness and side effects of the drugs used for their treatment.
[Methods] This observational retrospe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3063a8b17b1fa3b84561fb7aabdd72
https://hdl.handle.net/11268/11525
Zobrazit plný text záznamu
8
Estimación del efecto del metilfenidato en el rendimiento académico de los niños con TDAH y qué efectos secundarios puede ocasionar
Autor: Morales Renau, Genís
Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
Treballs Finals de Grau en Estadística UB-UPC, Facultat d'Economia i Empresa (UB) i Facultat de Matemàtiques i Estadística (UPC), Curs: 2020-2021, Tutor: Jose Antonio González Alastrúe
El trastorno por déficit de atención e hiperactividad
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2016146e8c67762f1e503efba1b77054
http://hdl.handle.net/2445/182411
Zobrazit plný text záznamu
9
Epidemiological study of aromatase inhibitors in women diagnosed with breast cancer: evaluation and management of secondary effects
Autor: Pineda Moncusí, Marta
Publikováno v: Dipòsit Digital de la UB
Universidad de Barcelona
TDX (Tesis Doctorals en Xarxa)
TDR. Tesis Doctorales en Red
instname
TDR: Tesis Doctorales en Red
CBUC, CESCA
Aromatase inhibitors (AI) are one of the main therapies to treat estrogen-receptor positive breast cancer. AI use is associated with several side effects that affects patient’s quality of life and reduces treatment adherence. Hence, it is necessary
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::321ba32ad5b9c10b043fd716139b1c7d
http://hdl.handle.net/10803/672258
Zobrazit plný text záznamu
10
Drugs that increase the risk of community-acquired pneumonia: a narrative review
Autor: Antoni Torres, Adamantia Liapikou, Catia Cilloniz
Publikováno v: Recercat. Dipósit de la Recerca de Catalunya
instname
Dipòsit Digital de la UB
Universidad de Barcelona
INTRODUCTION: Community-acquired pneumonia (CAP), a major cause of morbidity and mortality, is the leading infectious cause of death in the developed world. Population-based studies and systematic reviews have identified a large number of risk factor
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::484c7ddeab71ebe21e32ede7bf15ce7e
https://doi.org/10.1080/14740338.2018.1519545
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje